Portfolio company
Outpace Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
11 investors
Sectors
About
This biotechnology company develops custom protein-designed cell therapies to treat solid tumours and autoimmune diseases for patients and pharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Outpace
This biotechnology company develops custom protein-based biological software to create smart cell therapies for patients with cancer and autoimmune diseases.
Modulari-T Biosciences
This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.
Waypoint Bio
This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.
OverT Bio
This company develops engineered cell therapies and genetic screening platforms to treat patients with solid tumour cancers.
OverT
This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.
Alceus
This company develops a platform that uses artificial intelligence to design therapeutic proteins and program immune cells for clinicians and researchers treating solid tumours.
Ditto Biosciences
The company develops parasite-derived protein therapies for pharmaceutical and biotechnology partners to treat patients with autoimmune diseases using an artificial intelligence platform.
Strand Therapeutics
This biotechnology company develops programmable messenger RNA therapies for patients with solid tumours and autoimmune diseases.
